Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing ...
Mar 23, 2015
0
30
About 2.6 billion people—nearly half of the global population, most of them in Africa, Asia and central and south America—rely on biomass fuels, like wood and charcoal, or kerosene to cook meals, heat and light their ...
Jun 29, 2022
0
9
An international team of researchers have put forward a position statement, published in Science, which lays out a new healthcare framework to help aging populations stay healthier for longer.
Oct 31, 2019
1
103
Overweight patients with atrial fibrillation are more likely to experience a return of the heart rhythm disorder after a corrective procedure than those of normal weight, according to research presented at EHRA 2022, a scientific ...
Apr 4, 2022
0
55
A new study published by University of Toronto researchers suggests that women who have never smoked are susceptible to Chronic Obstructive Pulmonary Disease (COPD) and that African American women are particularly vulnerable. ...
Dec 9, 2016
0
14
In a recent paper published in the journal Skeletal Muscle, a Saint Louis University researcher reports success in identifying new drug targets that potentially could slow or halt the progression of a form muscular dystrophy, ...
Nov 7, 2017
0
251
Patients with esophageal cancer who survive 5 years after undergoing surgery might breathe a sigh of relief and become complacent about continued monitoring. In fact, there is little published information on the outcome of ...
Apr 29, 2015
0
6
Scientists at the University of Illinois at Urbana-Champaign and Mie University in Japan have developed monoclonal antibodies that prevent lung cell death in mouse models for idiopathic pulmonary fibrosis (IPF) and acute ...
Mar 23, 2022
0
77
Scientists at Los Alamos National Laboratory are developing a miniature, tissue-engineered artificial lung that mimics the response of the human lung to drugs, toxins and other agents.
Apr 26, 2016
0
41
Ann Shulgin, who together with her late husband Alexander Shulgin pioneered the use of psychedelic drugs in psychotherapy and co-wrote two seminal books on the subject, has died at the age of 91.
Jul 12, 2022
0
4
